Tim Nash Patient

Tim Nash first heard about Road to Victories when the cross-country riders rode through his town last year. As a patient who was diagnosed in 2015, Tim was inspired by the group and went to meet the team at their hotel, surprising them with a visit. Little did Tim know how much his visit inspired the team for the next 1000+ miles. He then flew out to be a participant in the final day ride, rode with the Red Rocks team in 2018 and is coming back for more R2V in 2019. Tim is excited to take on yet another challenge with his brother, Pat Nash by his side.

When Road to Victories came through my hometown
Tim Nash
That was the day, as I laid there feeling so miserable, that hope entered my life! Hope that I might still be able to do some of the things I…
Read More
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More